CODES, a novel procedure for ligand-based virtual screening: PDE7 inhibitors as an application example

European Journal of Medicinal Chemistry

Volumn 43, Issue 7, 2008, Pages 1349-1359

  Castro, Ana ^a   Jerez, María José ^a   Gil, Carmen ^a   Calderón, Félix ^a   Doménech, Teresa ^b   Nueda, Arsenio ^b   Martínez, Ana ^a  

^a INSTITUTO DE QUÍMICA MÉDICA   (Spain)

^b Almirall Prodesfarma ^*  (Spain)

Author keywords

CODES; PDE7; Virtual screening

Indexed keywords

CYCLIC AMP; PHOSPHODIESTERASE VII INHIBITOR;

ARTICLE; ATOM; CHEMICAL STRUCTURE; COMPUTER PROGRAM; STEREOISOMERISM; SYNTHESIS; VIRTUAL REALITY;

CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 7; LIGANDS; MAGNETIC RESONANCE SPECTROSCOPY; PHOSPHODIESTERASE INHIBITORS; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 45949101641     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2007.10.027     Document Type: Article

References (51)

1. Conti M., and Jin S.L. Prog. Nucleic Acid Res. Mol. Biol. 63 (1999) 1-38
2. Vig M., George A., Sen R., Durdik J., Rath S., and Bal V. Mol. Pharmacol. 62 (2002) 1471-1481
3. Ritcher W. Proteins 46 (2002) 278-286
4. Allison A.C. Immunopharmacology 47 (2000) 63-83
5. Essayan D.M. Biochem. Pharmacol. 57 (1999) 965-973
6. Lugnier C. Pharmacol. Ther. 109 (2006) 366-398
7. Dyke H.J., and Montana J.G. Exp. Opin. Invest. Drugs 11 (2002) 1-13
8. Spina D. Drugs 63 (2003) 2575-2594
9. Menniti F.S., Faraci W.S., and Schmidt C.J. Nat. Rev. Drug Discov. 5 (2006) 660-670
10. O'Donnell J.M., and Zhang H.T. Trends Pharmacol. Sci. 25 (2004) 158-163
11. Birk S., Edvinsson L., Olesen J., and Kruuse C. Eur. J. Pharmacol. 489 (2004) 93-100
12. Pérez-Torres S., Cortes R., Tolnay M., Probst A., Palacios J.M., and Mengod G. Exp. Neurol. 182 (2003) 322-334
13. Ekholm D., Hemmer B., Gao G., Vergelli M., Martin R., and Manganiello V. J. Immunol. 159 (1997) 1520-1529
14. Erdogan S., and Houslay M.D. Biochem. J. 321 (1997) 165-175
15. Giembycz M.A., Corrigan C.J., Seybold J., Newton R., and Barnes P.J. Br. J. Pharmacol. 118 (1996) 1945-1958
16. Manning C.D., Burman M., Christensen S.B., Cieslinski L.B., Essayan D.M., Grous M., Torphy T.J., and Barnette M.S. Br. J. Pharmacol. 128 (1999) 1393-1398
17. Essayan D.M., Kagey-Sobotka A., Lichtenstein L.M., and Huang S.K. J. Pharmacol. Exp. Ther. 282 (1997) 505-512
18. Houslay M.D., Schafer P., and Zhang K.Y.J. Drug Discov. Today 10 (2005) 1503-1519
19. Chung K.F. Eur. J. Pharmacol. 533 (2006) 110-117
20. Giembycz M. Curr. Opin. Pharmacol. 5 (2005) 238-244
21. Li L., Yee C., and Beavo J.A. Science 283 (1999) 848-851
22. Nakata A., Ogawa K., Sasaki T., Koyama N., Wada K., Kotera J., Kikkawa H., Omori K., and Kaminuma O. Clin. Exp. Immunol. 128 (2002) 460-466
23. Yang G., McIntyre K.W., Townsend R.M., Shen H.H., Pitts W.J., Dodd J.H., Nadler S.G., McKinnon M., and Watson A.J. J. Immunol. 171 (2003) 6414-6420
24. Smith S.J., Cieslinski L.B., Newton R., Donnelly L.E., Fenwick P.S., Nicholson A.G., Barnes P.J., Barnette M.S., and Giembycz M.A. Mol. Pharmacol. 66 (2004) 1679-1689
25. Martínez A., Castro A., Gil C., Miralpeix M., Segarra V., Doménech T., Beleta J., Palacios J.M., Ryder H., Miró X., Bonet C., Casacuberta J.M., Azorín F., Piña B., and Puigdoménech P. J. Med. Chem. 43 (2000) 683-689
26. Castro A., Abasolo M.I., Gil C., Segarra V., and Martínez A. Eur. J. Med. Chem. 36 (2001) 333-338
27. Castro A., Jerez M.J., Gil C., and Martínez A. Med. Res. Rev. 25 (2005) 229-244
28. Whittle M., Gillet V.J., and Willett P. J. Chem. Inf. Comput. Sci. 44 (2004) 1840-1848
29. Barbosa F., and Dragos H. Curr. Top. Med. Chem. 4 (2004) 589-600
30. Ochoa C., Rodríguez J., Rodríguez M., Chana A., Stud M., Alonso-Villalobos P., and Martínez-Grueiro M.M. Med. Chem. Res. 7 (1998) 530-545
31. Martínez A., Castro A., Stud M., Rodríguez J., Cardelús I., Llenas J., Fernández A., and Palacios J.M. Med. Chem. Res. 8 (1999) 171-180
32. Dorronsoro I., Chana A., Abasolo M.I., Castro A., Gil C., Stud M., and Martínez A. Quant. Struct. -Act. Relat. 23 (2004) 89-98
33. Quiñones C., Cáceres J., Stud M., and Martínez A. Quant. Struct. -Act. Relat. 19 (2000) 448-454
34. Willett P. J. Chem. Inf. Comput. Sci. 38 (1998) 983-996
35. Bender A., Mussa H.Y., Gill G.S., and Glen R.C. J. Med. Chem. 47 (2004) 6569-6583
36. Xu H., and Agafiotis D.K. Curr. Top. Med. Chem. 2 (2002) 1305-1320
37. Pöter T., and Matter H. J. Med. Chem. 41 (1998) 478-488
38. Martínez A., Gil C., Castro A., Bruno A.M., Pérez C., Prieto C., and Otero J. Antiviral Chem. Chemother. 14 (2003) 107-114
39. Wu Y.-Q., Limburg D.C., Wilkinson D.E., and Hamilton G.S. J. Heterocycl. Chem. 40 (2003) 191-193
40. Garin J., Meléndez E., Merchán F.L., Tejero T., and Villarroya E. Synthesis 5 (1983) 406-408
41. Choo H.Y.P., Kim M., and Lee S.K. Bioorg. Med. Chem. 10 (2002) 517-523
42. Das N.B., and Mittra A.S. J. Indian Chem. Soc. 56 (1979) 398-400
43. Bhargava P.N., and Ram P. Bull. Chem. Soc. Jpn. 38 (1965) 342-344
44. Muthusamy S., and Ramakrishnan V.T. Synth. Commun. 22 (1992) 519-533
45. Shafik R.M., Hazzaa A.A.B., and Habib N.S. Pharmazie 34 (1979) 148-150
46. Barton D.H.R., Crich D., and Kretzschmar G. J. Chem. Soc., Perkin Trans. 1 (1986) 39-53
47. Cohen E., and Klarberg B. J. Am. Chem. Soc. 84 (1962) 1994-2002
48. Martínez A., Esteban A.I., Castro A., Gil C., Andrei G., Snoeck R., Balzarini J., and De Clerq E. Antiviral Chem. Chemother. 11 (2000) 221-230
49. Raheja D.H., Fulwadhva U.P., and Laxmeshwar N.B. J. Indian Chem. Soc. 61 (1984) 584-585
50. Ferris J.P., Singh S., and Newton T.A. J. Org. Chem. 44 (1979) 173-178
51. Beck R.B. J. Org. Chem. 37 (1972) 3224-3226